Skip to main content

Table 1 Panel A. Baseline Characteristics as mean (SD) or median (25–75%)

From: The effects of differing anticoagulant regimes on blood quality after cell salvage in coronary artery bypass grafting (CABG): a pilot study

Parameter

All (n = 38)

Citrate (n = 19)

Heparin (n = 19)

p-value

Panel A. Baseline

Age

64.2 (10.7)

62.6 (10.8)

65.8 (10.6)

0.362

Gender

M 31 (82%) F 7 (18%)

M 14 (74%) F5 (26%)

M 17 (89%) F2 (11%)

0.209

EUROSCORE II (%)

0.84 (0.65–1.86)

0.83 (0.60–1.28)

0.82 (0.71–2.46)

0.506

BMI

30.5 (5.3)

30.4 (5.6)

30.5 (5.1)

0.984

CABG ECC time (min)

142 (27)

135 (29)

150 (22)

0.080

CABG clamp time (min)

118 (29)

116 (30)

121 (29)

0.590

reperfusion time (min)

14 (11–23)

14 (9–17)

19(12–24)

0.221

Panel B. Cell saver BCR

Hb (g/dL)

9.5 (8.0–10.6)

9.9 (7.1–10.7)

9.4 (8.5–10.8)

0.443

Hct (%)

26.5 (24.2–31.7)

29.8 (23.1–36.1)

26.4 (24.8–31.2)

0.977

IL-6 (pg/ml)

3969.00 (2022.50–7004.50)

3848 (1422.75–7073.25)

3994 (2569.00–6741.00)

0.730

IL-8 (pg/ml)

412,01 (175.97–596.00)

417.10 (168,35–681.35)

412.01 (216.82–558.64)

0.822

IL-10 (pg/ml)

163.85 (74.28–266.94)

203.70 (108.98–411.42)

108.10 (60.00–176.71)

0.013

MPO (ng/ml)

870.0 (281.7)

871.9 (301.8)

868.2 (269.5)

0.969

Panel C. Washed RBC concentrate

Hb (g/dl)

19.6 (2.1)

18.1 (1.3)

21.1 (1.6)

< .001

Ht (%)

61.2 (56.6–64.2)

59.9 (54.7–60.9)

63.7 (62.3–64.8)

< .001

RBC (*106/ml)

6.8 (5.9–7.2)

6.0 (5.4–6.3)

7.2 (7.0–7.4)

< .001

MCV (fL)

93.9 (8.9)

99.1 (9.4)

88.7 (4.2)

< .001

MCH (pg)

30.3 (1.5)

30.6 (1.4)

29.9 (1.5)

0.172

MCHC (g/dl)

33.0 (31.8–33.7)

31.9 (29.6–32.4)

33.6 (33.1–34.0)

< 0.001

RDW (%)

13.9 (13.6–15.0)

14.5 (13.7–15.5)

13.7 (13.2–14.8)

0.032

Thrombocytes (*1000/ml)

26.5 (12.0–41.8)

31.0 (26.0–77.0)

13.0 (10.0–39.0)

0.006

FHb (mg/dL)

158 (118–217)

156 (118–218)

160 (109–202)

0.908

iron (μg/dL)

24.0 (20.8–27.0)

22.0 (19.0–27.0)

24.0 (22.0–29.0)

0.258

WBC count (*1000/ml)

12.9 (9.7–19.0)

14.3 (9.7–22.4)

12.1 (7.5–16.7)

0.297

Neutrophils (%)

91.0 (86.0–95.0)

86.0 (85.0–91.0)

95.0 (90.0–97.0)

< 0.001

Lymphocytes (%)

6.0 (2.75–10.25)

10.0 (6.0–12.0)

4.0 (2.0–6.0)

< 0.001

Monocytes (%)

1.0 (0.0–1.0)

1.0 (1.0–2.0)

1.0 (0.0–1.0)

0.014

Eosinopils (%)

1.0 (0.0–1.0)

1.0 (1.0–2.0)

1.0 (0.0–1.0)

0.043

Basophiles (%)

0.0 (0.0–0.0)

0.0 (0.0–0.0)

0.0 (0.0–1.0)

0.563

Neutrophils (*1000/ml)

12.0 (8.1–17.4)

13.0 (9.2–20.5)

11.7 (6.3–15.9)

0.603

Lymphocytes(*1000/ml)

1.0 (0.4–1.6)

1.3 (1.1–2.4)

0.4 (0.2–0.7)

< 0.001

Monocytes (*1000/ml)

0.10 (0.08–0.30)

0.2 (0.1–0.3)

0.1 (0.0–0.1)

0.014

Eosinophils (*1000/ml)

0.1 (0.1–0.2)

0.1 (0.1–0.2)

0.1 (0.0–0.1)

0.006

Basophiles (*1000/ml)

0.0 (0.0–0.1)

0.0 (0.0–0.0)

0.0 (0.0–0.1)

0.435

  1. Euroscore is a validated score to evaluate the risk of cardiac surgery (Nashef et al. EuroSCORE II. Eur J Cardio-thorac. 2012) [13]. BCR values were reported as mean (SD) or median (25–75%). Panel C. Values for washed RBC concentrate were reported as mean (SD) or median (25–75%)
  2. Bold value < than 0.05 i.e. statistically significant
Back to article page

Journal of Cardiothoracic Surgery

ISSN: 1749-8090

Contact us